RNA Therapeutics Inc.
Newark, DE
- UEI
- DLVLULLCPB38
- CAGE
- Not on record
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 254 Chapman Rd ste 208, Newark, DE 19702, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of a pan-covid-19 vaccine candidate | National Institute of Allergy and Infectious Diseases (NIH) | $299,967 |
Quick answers
Is RNA Therapeutics Inc. registered in SAM.gov?
Yes. RNA Therapeutics Inc.'s SAM.gov registration is active through December 16, 2026.
What is RNA Therapeutics Inc.'s most recent federal award?
RNA Therapeutics Inc.'s most recent federal grant award is Development of a pan-covid-19 vaccine candidate (R41AI181134), from National Institute of Allergy and Infectious Diseases (NIH), on March 13, 2024.
On GovTribe
See RNA Therapeutics Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors